Skip to main content
Premium Trial:

Request an Annual Quote

Virax Biolabs, Cosmos Holdings Ink Distribution Deal for Monkeypox PCR Test

NEW YORK – Virax Biolabs announced on Thursday that it has signed a deal with Cosmos Holdings to distribute Virax's monkeypox PCR tests in Europe.

Under the agreement, Cosmos will have exclusive distribution rights for Greece and Cyprus for the Monkeypox Virus Real-Time PCR Detection Kits. Cosmos will also have the opportunity to nonexclusively distribute the tests across Europe, Virax said in a statement. 

Financial and other terms of the deal were not disclosed.

The assay is intended to provide a preliminary diagnosis of monkeypox virus from human serum and lesion exudate specimens. 

"Based on our conversations with our customers, we see a strong demand for fast and conducive testing methods for monkeypox virus," Cosmos CEO Greg Siokas said in a statement. 

Virax CEO and Chairman James Foster said in a statement that the company is working to sign additional regional partnerships for the test globally. 

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.